Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719–48.PubMed 15. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177–88.PubMedCrossRef 16.

Tobias A: Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999, 8:15–7. 17. Egger M, Davey Smith G, Schneider M, Minder C: Bias in metaanalysis detected by a simple, graphical test. BMJ 1997, 315:629–34.PubMedCrossRef 18. Tefre T, Ryberg D, Haugen A, Nebert DW, Skaug V, Brogger A, Borresen AL: Human CYP1A1 (cytochrome selleck chemicals P450) gene: lack of association between the MspI restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1991, 1:20–25.PubMedCrossRef 19. Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Anttila S, Vainio H: Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev 1992, 1:485–9.32.PubMed 20. Shields PG, Caporaso NE, Falk RT, Sugimura

H, Trivers GE, Trump BF, Hoover RN, Weston A, Harris CC: Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev 1993,2(5):481–5.PubMed 21. Nakachi K, Imai K, Hayashi S, Kawajiri K: Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette Nintedanib (BIBF 1120) check details dose in a Japanese population. Cancer Res 1993, 53:2994–9.PubMed 22. Alexandrie AK, Sundberg MI, Seidegård J, Tornling G, Rannug A: Genetic susceptibility to lung cancer

with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 1994, 15:1785–90.PubMedCrossRef 23. Kelsey KT, Wiencke JK, Spitz MR: A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis 1994, 15:1121–4.PubMedCrossRef 24. Kihara M, Kihara M, Noda K: Risk of smoking for squamous and small cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis 1995, 16:2331–6.PubMedCrossRef 25. Cantlay AM, Lamb D, Gillooly M, Norrman J, Fludarabine clinical trial Morrison D, Smith CA, Harrison DJ: Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer. Clin Mol Pathol 1995, 48:M210-M214.PubMedCrossRef 26. Xu X, Kelsey KT, Wiencke JK, Wain JC, Christiani DC: Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1996, 5:687–92.PubMed 27. Ishibe N, Wiencke JK, Zuo ZF, McMillan A, Spitz M, Kelsey KT: Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican and African-Americans. Cancer Epidemiol Biomarkers Prev 1997, 6:1075–80.PubMed 28.